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What's your favorite experiment? My favorite study of all time was published in Science in 1971 by Peter Eimas and his collaborators. They discovered a way to investigate how human infants perceive speech. The study was game changing both theoretically (demonstrating very early perceptual skills that were previously unknown) and methodologically (demonstrating that infant behavior could be tapped to understand how infants represent speech sounds). In terms of my own studies, I'd have to say that my favorite experiment comes from the 1996 paper that I published in Science with my graduate mentors, Elissa Newport and Dick Aslin. In that work, we tested the hypothesis that infants were sensitive to the statistical patterns of speech, i.e., which syllables tend to follow which others -patterns that provide a cue to word boundaries in fl uent speech. We demonstrated that eight-month-old infants can detect these types of patterns after just a few minutes of exposure. This was important at the time because it opened up new ways of thinking about the power of infant learning abilities.
What is the best advice you've been given? When I started graduate school, my mother said that her hope was that, by the time I fi nished my PhD, I would have settled on a research question that drove me. At the time, I thought her advice was backwards -wasn't I supposed to start graduate school with that burning question in mind? But I came to understand that the whole point of graduate school was to develop the tools -intellectual and technicalthat would get me into a space where I could see the universe of questions to be addressed. I didn't see them when I started grad school. I am grateful to my mom for her forward-thinking advice and to my graduate mentors for helping me so much on the road to fi nding my question (how do infants learn?), which motivates me to this day.
If you had not made it as a scientist, what would you have become?
My deepest aspiration was to be a musician -and indeed I did consider becoming a professional classical musician. But I don't have the temperament for it; classical music practice makes science look easy, and classical musicians make scientists look relaxed. In actuality, I probably would have gotten a Master's degree in public health and become an epidemiologist. I love the idea of using statistics and demographics to trace disease outbreaks or to fi gure out the factors that lead to public health problems, such as obesity and addiction. I could also imagine using my enjoyment of numbers to become a political pollster, though that occupation seems somewhat thankless these days.
Which aspect of science, your fi eld or in general, do you wish the general public knew more about? I wish that the general public knew more about bilingualism. The opportunity for a child to become bilingual is such a gift, but many parents are wary of 'confusing' their child through exposure to multiple languages. Fortunately for kids, the data don't bear out that fear. Learning additional languages earlier in life is vastly easier for most people than learning them in school. And unfortunately, the age at which languages are generally taught in school is too late to achieve fl uency for most people. Societal emphasis on earlier language exposure, rather than requiring that languages be taught in secondary school and/or university, would lead to more widespread second language fl uency. 
Who has them, and how many?
All multicellular eukaryotes have TRIM proteins; how many depends on how far along the evolutionary tree a species is. The number of TRIM genes ranges from 6 in fruit fl ies, to over 70 in humans. The TRIM repertoire steadily increased up to around 30 TRIM genes in non-jawed vertebrates. For the most part, these evolutionarily older TRIMs are thought to have conserved biological functions, such as control of cell proliferation and differentiation. However, at the time of the emergence of jawed vertebrates and the increase in the complexity of the immune system, the TRIM gene number rapidly increased to 60-80 in mammals. Many of these newly acquired TRIMs are induced by cytokines, have direct antiviral activities, or regulate the immune system.
What do the different protein domains contribute to TRIM function?
Given the diversity in the TRIM family, it is no surprise that many different functions of the individual domains have been reported. Yet, some generalities can be identifi ed. First of all, the aminoterminal RING domain is a zinc fi nger characteristic of E3 ubiquitin ligases. Although many TRIM proteins have been shown to exert their biological functions through ubiquitination, various ubiquitinindependent functions have also been reported. The Bbox domains are zinc fi ngers similar to the RING domain, yet
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are not thought to confer ubiquitin ligase activity. In fact, the roles of these domains remain the least characterized, although in some cases they contribute to higher-order protein complex formation. The coiled-coil mediates TRIM protein multimerization, which often is important for biological function. More recently, the coiled coil was also shown in some TRIM proteins to contain LIR motifs, important for interaction with autophagy receptors. The carboxy-terminal domains are unique to each TRIM member, and often interact with specifi c proteins, allowing for differential function. For example, for most TRIMs with ubiquitin ligase activity, the carboxy-terminal domain determines target specifi city.
Where are TRIM proteins expressed?
Many TRIMs are ubiquitously expressed, yet can have different biological functions depending on their cellular context. mRNA expression profi ling indicates that about a third of all TRIMs have varying degrees of cell-type specifi city in their expression, which often translates into specifi c biological roles in these cells. A striking example is a trifecta of TRIMs better known as muscle RING fi nger proteins (MuRFs), which are predominantly expressed in cardiac and skeletal muscle, each member at different developmental stages. Mouse studies have revealed their partially redundant roles in proper heart and skeletal muscle development, and in the ability to adapt to stress during cardiac injury.
How do TRIMs mediate direct antiviral activity?
Various different TRIM family members have been recognized to have important direct antiviral effector functions, albeit through highly divergent molecular mechanisms. One of the best recognized direct effectors is TRIM5, which has antiviral activity against retroviruses. The molecular mechanism underlying this function involves the formation of a multimeric hexagonal TRIM5 'net' through its tripartite motif, which captures the retroviral capsid and interferes with uncoating of the viral genome by targeting the capsid for autophagosomal destruction. The biological importance of TRIM5 is underpinned by the fact that its gene has been under strong positive selection pressure to adapt to changing viral capsids. Another TRIM protein -TRIM21x -has been shown to bind strongly to IgG constant regions through its carboxy-terminal B30.2 domain, allowing it to function as a cytoplasmic antibody receptor. Upon binding of opsonized pathogens and their proteins, the TRIM21 RING domain targets its antibody-bound proteins for ubiquitination and proteasomal degradation, as well as facilitating innate immune signaling. This TRIM21 property has recently been developed into a fast protein knockdown method ('TRIM-Away'), which relies on cytoplasmic delivery of an antibody against a protein of interest, thereby targeting it for rapid TRIM21-dependent proteasomal degradation. 
Function

Are other TRIMs besides TRIM5 involved in autophagy?
Indeedabout half of all TRIM proteins have been identifi ed in genetic screens to contribute to autophagy. Most autophagy-associated TRIMs mediate binding both to components of the core autophagy machinery and to receptors that recognize ubiquitinated autophagy cargo. These complexes have been dubbed TRIMosomes and are thought to facilitate recognition and targeting of specifi c substrates in a wide array of different cellular processes for autophagic engulfment and subsequent lysosomal destruction. Some of the identifi ed predominant autophagy targets include viral components, such as the HIV capsid (targeted by TRIM5), and herpes simplex virus (targeted by TRIM23 through a noncanonical autoubiquitination-dependent mechanism). Moreover, TRIM proteins have been shown to target several factors that promote innate immunity, thereby curtailing these responses.
How do TRIM proteins regulate immune cell signaling?
Many different TRIM proteins have been implicated in enhancing, but also inhibiting, innate immune signaling in the antiviral type I interferon, antifungal, pro-infl ammatory NF-kB and infl ammasome pathways. In most cases, specifi c cellular immune regulatory proteins are targeted by individual TRIMs through their unique specifi city-determining carboxy-terminal domains, and exert their biological effects through polyubiquitination. One well-recognized example is TRIM25, which acts as an activator of a key viral RNA sensor through the synthesis of activating polyubiquitin chains. The biological importance of this antiviral pathway is demonstrated by the fact that infl uenza A viruses have evolved an antagonist to actively interfere with TRIM25 function, thereby diminishing the activation of their cellular sensor and ultimately the expression of antiviral cytokines.
Is there a link between TRIMs and autoimmune diseases?
Unsurprisingly -given the plethora of immune-regulatory functionsdysregulation of several TRIMs contributes to immune diseases, such as systemic lupus erythematosus, Sjögren's syndrome, infl ammatory bowel disease, and familial Mediterranean fever (FMF). The latter is one of the best-defi ned examples where mutations in a single TRIM family member -TRIM20, which regulates infl ammasome activity -are the cause of a heritable pro-infl ammatory disease. Studies with Trim20 transgenic and knock-out mice suggest that both gain-and loss-offunction mutations can cause FMF. This seemingly paradoxical notion could stem from the fact that two different domains in TRIM20 have been associated with its activation and its repression. This apparent dichotomy exemplifi es the complexity of TRIM protein regulation and functions, and underpins that mutations in different TRIM protein regions can have opposite biological outcomes.
Are any TRIM proteins associated with cancer? Yes! The diversity in cellular proliferative and differentiation functions mediated by different TRIM proteins is refl ected in the range of cancers associated with aberrant TRIM protein expression or activity.
Approximately a third of all TRIM family members have been associated with different human cancers. About half of this TRIM subset has reported oncogenic potential and increased expression in tumor tissue, whereas the other half has been suggested to result from tumor suppressor loss-of-function. A small subset is thought to promote metastasis by dysregulation of the epithelial-tomesenchymal transition and increasing cell motility and invasion. Most known disease associations stem from altered TRIM protein activity or expression, yet in several welldefi ned cancers genetic translocations give rise to TRIM fusion proteins with oncogenic potential. One of the best known examples of the latter class is the promyelocytic leukemia protein (PML; also known as TRIM19), which is found in more than 98% of patients with acute promyelocytic leukemia as a balanced translocation with retinoic acid receptor . This dominant-negative fusion protein results in a loss of retinoic acid receptor -driven promyelocyte differentiation as the underlying etiology of this blood cancer.
What are some key questions that remain unanswered?
A central open question is how do certain TRIMs with ubiquitous expression exert different biological functions in different cell types. For example, mouse knock-out studies for TRIM21 with described immune-related roles have indicated that this protein can also play important specifi c roles, such as in cardiac redox homeostasis and protection against reactive oxygen species. This reveals that exclusive muscle tissue expression -as is the case for MuRFs -is not the sole determinant for cell-specifi c functions.
A contributing factor to this conundrum is that many TRIM proteins have isoforms that lack one or more of their characteristic domains. The level of expression of each isoform and how they infl uence each other's biological functions remains unclear. In fact, the contribution of several isoforms of the same TRIM to a phenotype could explain why sometimes opposing effects of their ablation or overexpression have been reported in different cell types. A prime example of this is PML/TRIM19, which is expressed as seven different isoforms, the abundance of which varies according to cell type. All isoforms have different biological functions, including direct viral restriction, PML nuclear body formation, and cytoplasmic innate immune signaling.
